However, closer scrutiny of these studies raises questions about the role of CD4 + T cells as the sole mediators of corneal graft rejection, as corneal allografts
undergo immune rejection in 33 % of the mice and 64 % of the rats treated with anti-CD4 monoclonal antibody (12, 13) and in 45 % of the CD4 KO mice (14).
«Cancer treatment for transplant patients discovered: Letter notes combination of steroids and immunosuppressants, combined with
immune checkpoint inhibitors helps prevent organ
rejection in kidney transplant patients
undergoing cancer treatment.»